US court lifts restrictions on Sun Pharma launching autoimmune disorder drug

Sun Pharmaceutical Industries Ltd announced that a US court has ruled in its favour, immediately vacating a preliminary injunction that restricted the launch of LEQSELVI, a drug for treating autoimmune-related hair loss. This decision follows a patent infringement litigation with Incyte Corporation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/mPDKE1J
via IFTTT